Global Health Limited (Medanta), one of India’s leading multi-specialty hospital chains, has reported a strong financial performance for the quarter ended December 31, 2024 (Q3 FY25), with 12.8% year-on-year (YoY) growth in revenue from operations.
Key financial highlights (Q3 FY25 vs. Q3 FY24)
- Revenue from operations: ₹943.4 crore, up 12.8% from ₹836.5 crore in Q3 FY24.
- Total income: ₹959.5 crore, an increase from ₹854.5 crore in the same quarter last year.
- EBITDA: ₹253.8 crore, compared to ₹238.0 crore in Q3 FY24.
- Profit after tax (PAT): ₹142.9 crore, up 15.6% from ₹123.5 crore in Q3 FY24.
- EBITDA margin: 26.9%, showing stable operational efficiency.
- Earnings per share (EPS): ₹5.32, compared to ₹4.61 in Q3 FY24.
Nine-month performance (April–December 2024 vs. April–December 2023)
- Revenue from operations: ₹2,761.1 crore, up 11.9% from ₹2,466.5 crore in the same period last year.
- Profit after tax (PAT): ₹379.9 crore, reflecting a 8.3% YoY increase.
- Total comprehensive income: ₹381.5 crore, up from ₹349.8 crore last year.
Medanta continues to expand its presence in key markets, with the company adding a 110-bed super-specialty hospital in Ranchi under a lease agreement. The new facility will enhance high-end tertiary and quaternary care services and strengthen Medanta’s presence in Eastern India.
Additionally, Medanta has signed a definitive agreement to operate and manage a 750-bed hospital in Pitampura, New Delhi, further strengthening its position in North India.
With a focus on expansion, operational efficiency, and high-end specialty care, Medanta remains committed to scaling its operations while maintaining profitability. The company’s EBITDA margins and revenue growth trajectory indicate sustained demand for quality healthcare services across India.
Ahmedabad Plane Crash